Gleison Tibau is currently on suspension for a potential failure in a random out of competition drug test from the US Anti-Doping Agency (USADA), and it was revealed on Wednesday that he also failed a drug test the night of his most recent fight at UFC Fight Night 77 in Brazil.
The UFC released a statement on Wednesday regarding the new test failure, which will likely overturn his already contentious non-submission submission “victory” over Abel Trujillo.
“The U.S. Anti-Doping Agency (USADA) has notified both Gleason Tibau and UFC of a potential Anti-Doping Policy violation stemming from an in-competition sample collected immediately after his bout in Sao Paulo, Brazil on November 7, 2015,” the UFC’s statement read. “Tibau and UFC were previously notified that he had been provisionally suspended due to a potential Anti-Doping Policy violation stemming from an out-of-competition test.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Tibau. Additional information will be provided at the appropriate time as the process moves forward.”
Tibau, one of the longest-tenured fighters in the organization, will receive formal punishment in the near future.
[Photo (c) Jason Silva via USA Today Sports]
Attention iPhone/iPad users, if you’ve enjoyed our app in the past and followed us there, or if you’ve never checked it out, make sure to update to the latest version in the Apple store. We’ve launched a new look for the app, in line with our recent desktop overhaul. Make sure to check it out! An update to our Android app is on its way soon as well, so Android users keep an eye out for that update soon!